TGFB1 and cancer: Interleukin (IL)-6, tumor necrosis factor (TNF)-α, and transforming growth factor (TGF)-β are also closely associated with several cancer-related symptoms and adverse events of anti-cancer therapy, such as cachexia and fatigue [5,6,7].